Evidence map›Paper›PMID 34856391›Full record

ArticleGenomics, proteomics & bioinformatics2022

CircR2Disease v2.0: An Updated Web Server for Experimentally Validated circRNA-disease Associations and Its Application.

Chunyan Fan, Xiujuan Lei, Jiaojiao Tie, Yuchen Zhang, Fang-Xiang Wu, Yi Pan

Abstract read
In one paragraph

Article in Genomics, proteomics & bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Online Databases in Circular RNAs.Advances in experimental medicine and biology · 2025
    Review
  16. Article
  17. Modeling ncRNA Synergistic Regulation in Cancer.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  18. MDDOmics: multi-omics resource of major depressive disorder.Database : the journal of biological databases and curation · 2024
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chunyan FanSchool of Computer Science, Shaanxi Normal University, Xi'an 710119, China.
Xiujuan LeiSchool of Computer Science, Shaanxi Normal University, Xi'an 710119, China. Electronic address: xjlei@snnu.edu.cn.
Jiaojiao TieSchool of Computer Science, Shaanxi Normal University, Xi'an 710119, China.
Yuchen ZhangSchool of Computer Science, Shaanxi Normal University, Xi'an 710119, China.
Fang-Xiang WuDivision of Biomedical Engineering, University of Saskatchewan, Saskatoon, SK S7N 5A9, Canada. Electronic address: faw341@mail.usask.ca.
Yi PanDepartment of Computer Science, Georgia State University, Atlanta, GA 30302, USA. Electronic address: yipan@gsu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With accumulating dysregulated circular RNAs (circRNAs) in pathological processes, the regulatory functions of circRNAs, especially circRNAs as microRNA (miRNA) sponges and their interactions with RNA-binding proteins (RBPs), have been widely validated. However, the collected information on experimentally validated circRNA-disease associations is only preliminary. Therefore, an updated CircR2Disease database providing a comprehensive resource and web tool to clarify the relationships between circRNAs and diseases in diverse species is necessary. Here, we present an updated CircR2Disease v2.0 with the increased number of circRNA-disease associations and novel characteristics. CircR2Disease v2.0 provides more than 5-fold experimentally validated circRNA-disease associations compared to its previous version. This version includes 4201 entries between 3077 circRNAs and 312 disease subtypes. Secondly, the information of circRNA-miRNA, circRNA-miRNA-target, and circRNA-RBP interactions has been manually collected for various diseases. Thirdly, the gene symbols of circRNAs and disease name IDs can be linked with various nomenclature databases. Detailed descriptions such as samples and journals have also been integrated into the updated version. Thus, CircR2Disease v2.0 can serve as a platform for users to systematically investigate the roles of dysregulated circRNAs in various diseases and further explore the posttranscriptional regulatory function in diseases. Finally, we propose a computational method named circDis based on the graph convolutional network (GCN) and gradient boosting decision tree (GBDT) to illustrate the applications of the CircR2Disease v2.0 database. CircR2Disease v2.0 is available at http://bioinfo.snnu.edu.cn/CircR2Disease_v2.0 and https://github.com/bioinforlab/CircR2Disease-v2.0.

Indexed as

MicroRNAsRNA, CircularDatabases, FactualGene Expression RegulationMicroRNAsRNA, CircularcircRNAcircRNA–disease associationGradient boosting decision treeGraph convolutional networkMachine learning

Identifiers

PMID34856391
PMCPMC9801044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.